Sleep Apnea: A Guide to Definition and Suggestions

International Journal of Business Society, Vol. 5, Issue 10
Yu YanmeiFioni*Ulina Karo-karo
ObesityOSAPublic healthSleep
PDFSpecial IssueDOI: 10.30566/ijo-bs/2021.special.16
5Volume
10Issue

Abstract

A condition known as Obstructive Sleep Apnea (OSA) is characterized by poor sleep quality, excessive daytime drowsiness, and impaired cognitive performance. As a result, it has long been regarded as a severe public health concern with possible social effects, such as higher morbidity and mortality, as well as cognitive deficiencies that affect job productivity. Recently, there has been a significant rise in the number of people identified with and cured with OSA. A worldwide condition with increased prevalence and comorbidities, particularly with metabolic syndrome, is OSA. Diabetes mellitus type 2 (T2DM), hypercholesterolemia, and hypertension are significant contributors to sleep apnea. To control OSA, CPAP treatment may be used. As worldwide awareness grows, health care systems provide prevention, diagnosis, and treatment. To reduce obesity, people need to be aware of exercising and changing their lifestyle habits (eating habits, smoking, drinking). Obesity and sleep apnea will be dramatically decreased if these lifestyle changes are widely adopted. To enhance quality of life, the public must be aware of weight reduction via diet and exercise. They may also lower the risk of other comorbidities such as cardiovascular disease, atherosclerosis, and depression associated with obesity. Finally, health care prices will fall.

References

[1]

M. Watanabe, H. Kikuchi, K. Tanaka, and M. Takahashi, "Association of short sleep duration with weight gain and obesity at 1-year follow-up: a large-scale prospective study," Sleep, vol. 33, no. 2, pp. 161-167, 2010.

[2]

H. H. Kang et al., "The associations between anthropometric indices and obstructive sleep apnea in a Korean population," PLoS One, vol. 9, no. 12, p. e114463, 2014.

[3]

Heraganahally, S. S., et al., Obstructive sleep apnoea and adherence to continuous positive airway therapy among Australian women. Internal Medicine Journal, 2020.

[4]

Hadi, A., Sepandi, M., Marx, W., Moradi, S., & Parastouei, K., Clinical and psychological responses to synbiotic supplementation in obese or overweight adults: A randomized clinical trial. Complementary therapies in medicine, 47, 102216, 2019.

[5]

Andersen, I. G., Holm, J.-C., & Homøe, P., Obstructive sleep apnea in children and adolescents with and without obesity. European Archives of Oto-Rhino-Laryngology, 276(3), 871-878, 2019.

[6]

Caloway, C. L., et al., Update on hypoglossal nerve stimulation in children with down syndrome and obstructive sleep apnea. The Laryngoscope, 130(4), E263-E267, 2020.

[7]

Sward, M., Kirk, C., Kumar, S., Nasir, N., Adams, W., and Bouchard, C., Lax eyelid syndrome (LES), obstructive sleep apnea (OSA), and ocular surface inflammation. The Ocular Surface, 16(3), 331-336, 2018.

[8]

Li, X., et al., Excessive daytime sleepiness, metabolic syndrome, and obstructive sleep apnea: two independent large cross-sectional studies and one interventional study. Respiratory Research, 20(1), 1-8, 2019.

[9]

de Carvalho, T. R., Blume, C. A., Alessi, J., Schaan, B. D., & Telo, G. H., Polysomnography in pre-operative screening for obstructive sleep apnea in patients undergoing bariatric surgery: a retrospective cohort study. International Journal of Obesity, 1-7, 2022.

[10]

Morsy, N. E., et al., Obstructive sleep apnea: personal, societal, public health, and legal implications. Reviews on Environmental Health, 34(2), 153-169, 2019.

[11]

Chen, T., et al., Prenatal, perinatal, and early childhood factors associated with childhood obstructive sleep apnea. The Journal of Pediatrics, 212, 20-27.e10, 2019.

Article Information

Article Details
Volume & IssueVol. 5, Iss. 10
Publication DateDec 1, 2021
Authors
Yu Yanmei
Fioni*
Ulina Karo-karo
DOI
10.30566/ijo-bs/2021.special.16
PDF Download